The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
regulus therapeutics | 10 |
rosetta genomics | 4 |
isis pharmaceuticals | 2 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
oligomeric compounds and compositions for use in modulation of small non-coding rnas | 57 | 2003 |
microrna compounds and methods for modulating mir-21 activity | 43 | 2011 |
microrna compounds and methods for modulating mir-21 activity | 41 | 2012 |
methods for treatment of alport syndrome | 35 | 2012 |
targeting micrornas for the treatment of liver cancer | 24 | 2007 |
microrna compounds and methods for modulating mir-122 | 23 | 2013 |
targeting micrornas for metabolic disorders | 19 | 2014 |
methods for use in modulating mir-122a | 15 | 2005 |
compounds and methods for enhanced cellular uptake | 12 | 2013 |
targeting micrornas for the treatment of fibrosis | 11 | 2010 |